Elevated Serum Level of Fas Ligand Correlates With the Asymptomatic Stage of Human Immunodeficiency Virus Infection

This publication has 16 references indexed in Scilit:

• Differential Susceptibility to HIV-GP120–Sensitized Apoptosis in CD4+ T-Cell Clones With Different T-Helper Phenotypes: Role of CD95/CD95L Interactions
  Blood, 1997
• Release of preformed Fas ligand in soluble form is the major factor for activation‐induced death of Jurkat T cells
  Immunology, 1996
• Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children
  Blood, 1996
• HIV‐1 upregulates Fas ligand expression in CD4⁺ T cells in vitro and in vivo : association with Fas‐mediated apoptosis and modulation by aurintricarboxylic acid
  Immunology, 1996
• Fas ligand in human serum
  Nature Medicine, 1996
• Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes
  Journal of Virology, 1996
• Metalloproteinase-mediated release of human Fas ligand.
  The Journal of Experimental Medicine, 1995
• T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons.
  The Journal of Experimental Medicine, 1995
• Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals.
  The Journal of Experimental Medicine, 1995
• Expression of the functional soluble form of human fas ligand in activated lymphocytes.
  The EMBO Journal, 1995